Mallinckrodt is a Missouri-based specialty biopharmaceutical company that develops and commercializes medicines for the treatment of autoimmune and rare diseases.
Business Model:
Revenue: $2B
Employees: 1,001-5,000
Address: 675 McDonnell Boulevard
City: St. Louis
State: MO
Zip: 63042
Country: US
Mallinckrodt is a Missouri-based specialty biopharmaceutical company that develops and commercializes medicines for the treatment of autoimmune and rare diseases.
Contact Phone:
+13146542000
Contact Email:
Listed Exchange:
OTCMKTS
IPO Date:
6/28/2013
Ticker Symbol:
MNKKQ
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2019 | Silence Therapeutics | Post-IPO Equity | 0 |
7/2019 | Silence Therapeutics | Post-IPO Equity | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2013 | IPO | - | 6/2013 | IPO | - |
---|
Announced Date | Name | Price |
---|---|---|
12/2017 | Sucampo Pharmaceuticals | |
11/2017 | Ocera Therapeutics | |
8/2017 | InfaCare Pharmaceutical | |
8/2016 | Stratatech Corporation | |
8/2015 | Therakos | |
3/2015 | Ikaria | |
4/2014 | Questcor Pharmaceuticals | |
2/2014 | Cadence Pharmaceuticals | |
9/2012 | CNS Therapeutics (Old) | |
7/1997 | Nellcor Puritan Bennett |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|